These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3803416)

  • 1. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.
    Macphee GJ; McPhail EM; Butler E; Brodie MJ
    Eur J Clin Pharmacol; 1986; 31(2):195-9. PubMed ID: 3803416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbamazepine on psychomotor performance in näive subjects.
    MacPhee GJ; Goldie C; Roulston D; Potter L; Agnew E; Laidlaw J; Brodie MJ
    Eur J Clin Pharmacol; 1986; 30(1):37-42. PubMed ID: 3709630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.
    Larkin JG; McKee PJ; Brodie MJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):111-4. PubMed ID: 1540481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
    McKee PJ; Blacklaw J; Carswell A; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1993 Sep; 36(3):257-61. PubMed ID: 9114913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.
    Macphee GJ; Mitchell JR; Wiseman L; McLellan AR; Park BK; McInnes GT; Brodie MJ
    Br J Clin Pharmacol; 1988 Jan; 25(1):59-66. PubMed ID: 3130892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.
    McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):99-104. PubMed ID: 1888646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J
    Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication.
    Aman MG; Werry JS; Paxton JW; Turbott SH; Stewart AW
    Epilepsia; 1990; 31(1):51-60. PubMed ID: 2303013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
    Liu H; Delgado MR
    Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects.
    Wildin JD; Pleuvry BJ; Mawer GE
    Br J Clin Pharmacol; 1993 Jan; 35(1):14-9. PubMed ID: 8448063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function and time-of-day variation in serum carbamazepine concentration in epileptic patients treated with monotherapy.
    Reinvang I; Bjartveit S; Johannessen SI; Hagen OP; Larsen S; Fagerthun H; Gjerstad L
    Epilepsia; 1991; 32(1):116-21. PubMed ID: 1985819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function.
    van der Meyden CH; Bartel PR; Sommers DK; Blom M; Becker P; Erasmus S; Griesel D
    Epilepsia; 1992; 33(2):335-42. PubMed ID: 1547763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.